← Back to Search

Home Blood Pressure Self Management for Ischemic Stroke (HBPS Trial)

N/A
Waitlist Available
Research Sponsored by MedStar Georgetown University Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up three months
Awards & highlights

HBPS Trial Summary

This trial is testing a program to help stroke survivors in DC lower their blood pressure. The goal is to see if it's feasible and if it lowers blood pressure more than usual care.

Eligible Conditions
  • Ischemic Stroke
  • High Blood Pressure
  • Stroke

HBPS Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~three months
This trial's timeline: 3 weeks for screening, Varies for treatment, and three months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Feasibility of blood pressure self management in stroke survivors
Secondary outcome measures
Systolic Blood Pressure Difference

HBPS Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Home Blood Pressure Self ManagementExperimental Treatment1 Intervention
The HBPS group will check their blood pressure at home daily using a smart BP cuff with telemonitoring capability (Home Qardio) and guided to use a self-titration plan between office visits for persistently elevate blood pressures.
Group II: Usual CareActive Control1 Intervention
The Usual Care group will have their blood pressure monitored and medications adjusted by their primary care provider.

Find a Location

Who is running the clinical trial?

MedStar Georgetown University HospitalLead Sponsor
3 Previous Clinical Trials
22,747 Total Patients Enrolled
Medstar Health Research InstituteOTHER
191 Previous Clinical Trials
117,609 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~5 spots leftby May 2025